Al-Tourah, Abdulwahab J <br/><br/>
Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.  [electronic resource] 

 -  The Journal of urology  Dec 2005 
 - 2209-13, discussion 2213 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1097/01.ju.0000181810.22617.f8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>British Columbia<br/>Carcinoma, Embryonal--drug therapy<br/>Chemotherapy, Adjuvant<br/>Follow-Up Studies<br/>Humans<br/>Lymph Node Excision<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--therapy<br/>Neoplasm Staging<br/>Orchiectomy<br/>Population Surveillance<br/>Retroperitoneal Space<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Analysis<br/>Testicular Neoplasms--drug therapy<br/>Treatment Outcome